Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.
A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...
A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback